Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded
- Contract number
- SPE2DR26F8GWQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,782
Award facts
- Contract value 100% obligated
- $5,781.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $5,781.78 delivery order to AmerisourceBergen Drug Corp on July 14, 2026, for Dupixent 300 mg/2 mL syringes. The order is issued under the DLA Troop Support Medical indefinite delivery contract (SPE2DX series), which supports pharmaceutical supply to military healthcare systems globally. Place of performance is Conshohocken, PA. The order is firm fixed-price with an ultimate completion date of July 15, 2026.
Quick answers
Who was awarded contract SPE2DR26F8GWQ?
SPE2DR26F8GWQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 14, 2026.
How much is contract SPE2DR26F8GWQ worth?
The government has obligated $5,782 on SPE2DR26F8GWQ.
Is contract SPE2DR26F8GWQ an order under another contract?
Yes. SPE2DR26F8GWQ is a delivery order under SPE2DR25D7065, an indefinite delivery contract.
Was contract SPE2DR26F8GWQ competed?
The extent of competition for SPE2DR26F8GWQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award